David Larsen
Stock Analyst at BTIG
(3.27)
# 1,050
Out of 4,761 analysts
74
Total ratings
42.11%
Success rate
5.55%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $49.28 | -28.98% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $108.60 | +19.71% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $25.68 | +20.72% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $191.04 | +36.10% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $31.77 | +57.38% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $19.49 | +2.62% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $35.68 | +96.19% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $4.92 | +42.28% | 1 | Sep 17, 2024 | |
| PGNY Progyny | Downgrades: Neutral | n/a | $23.20 | - | 3 | Aug 7, 2024 | |
| VEEV Veeva Systems | Initiates: Buy | $240 | $225.79 | +6.29% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $4.79 | +46.14% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $5.46 | +156.41% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.21 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $39.72 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $72.37 | - | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $10.43 | +331.45% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $5.23 | +301.53% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $3.52 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.93 | - | 2 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $24.52 | +42.74% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.51 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $6.22 | +1,427.33% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $11.74 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $127.06 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $597.71 | -73.23% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $10.16 | +588.98% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $77.24 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $63.48 | +33.90% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $6.22 | +269.77% | 1 | Nov 2, 2017 |
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $49.28
Upside: -28.98%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $108.60
Upside: +19.71%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $25.68
Upside: +20.72%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $191.04
Upside: +36.10%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $31.77
Upside: +57.38%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $19.49
Upside: +2.62%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $35.68
Upside: +96.19%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $4.92
Upside: +42.28%
Progyny
Aug 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $23.20
Upside: -
Veeva Systems
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $225.79
Upside: +6.29%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $4.79
Upside: +46.14%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $5.46
Upside: +156.41%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.21
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $39.72
Upside: -
Oct 13, 2022
Initiates: Neutral
Price Target: n/a
Current: $72.37
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $10.43
Upside: +331.45%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $5.23
Upside: +301.53%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $3.52
Upside: -
Apr 29, 2022
Downgrades: Neutral
Price Target: n/a
Current: $6.93
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $24.52
Upside: +42.74%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $11.51
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $6.22
Upside: +1,427.33%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $11.74
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $127.06
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $597.71
Upside: -73.23%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $10.16
Upside: +588.98%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $77.24
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $63.48
Upside: +33.90%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $6.22
Upside: +269.77%